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ABSTRACT
Introduction: Brittle nails are fragile or split
nails; they affect 20% of the population and
may be primary or secondary to different con-
ditions. The aim of our studies was to evaluate
the efficacy and tolerability of a new water-
based nail-strengthening treatment containing
hyaluronic acid and Pistacia lentiscus with daily
application for a period of 1–3 months for one
study (n = 30) and up to 6 months for a second
study (n = 30).
Methods: In total, we enrolled 60 patients of
both sexes with brittle and weak nails due to
primary or secondary causes and evaluated the
efficacy of this new product using subjective
and objective methods: clinical evaluation,
assessment of photographs, onychoscopy eval-
uation, investigator and patient global assess-
ment, dynamic optical coherence tomography
(D-OCT) and reflectance confocal microscopy
(RCM).
Results: Studies subjects presented a statisti-
cally significant improvement in global assess-
ment scale (GAS) scores at 14 days
(GAS = 1.7 ± 0.6), 1 month (GAS = 1.4 ± 0.7)
and at 3 months (GAS = 1±0.7) versus the GAS
score obtained before treatment (1.9 ± 0.5)
(p\ 0.0001). From the Italian study at
6 months (n = 30) 76% of the patients had an
improvement in their nail appearance. Reduc-
tion in nail plate roughness with improved nail
resistance and decreased distal breakage were
the most evident benefits, demonstrated on
clinical and instrumental evaluations. No side
effects were reported. All patients reported an
improvement in nail appearance after using the
product for 1 month, 3 months and 6 months,
and had a positive opinion on the product.
Conclusions: This new product is an effective,
safe, and easy-to-use option for topical treat-
ment of brittle nails and primary nail fragility
and an adjuvant therapy in secondary nail fra-
gility. Moreover, its ease of application and
cosmetic qualities allow good compliance.
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Key Summary Points
Why Carry Out This Study?
Brittle nails affect 20% of the population,
with women affected more often than
men.
Nail fragility can present an important
cosmetic problem, which may also
interfere with everyday activities.
Treatment of brittle nails is usually a big
challenge for dermatologists, due to the
slow growth rate of the nail plate and the
difficulty in getting actives to penetrate
the nail tissue. Thus, the ideal topical
product for nail fragility should be easy to
apply and cosmetically acceptable.
What Was Learned from the Study?
The conclusions of our studies indicate
that this new product is an effective, safe,
and easy-to-use option for topical
treatment of nail brittleness, and its
cosmetic qualities facilitate better
treatment compliance.
The modern and sophisticated techniques
used in these clinical trials allow us to
demonstrate the true efficacy of this
topical product in improving nail
resistance and thickness, and hydrating
and protecting the periungual skin.
INTRODUCTION
Brittle nails are characterized by nail fragility
and splitting, with a rough, opaque nail plate.
This condition affects 20% of the population,
with women affected more often than men [1].
Environmental and occupational factors, such
as increasing age, can lead to progressive dehy-
dration of the nail plate and play an important
role in the development of nail brittleness (id-
iopathic/primary nail fragility) [2, 3]. Nail
exposure to exogenous irritants and allergens
also contributes to fragility, damaging the
periungual tissues and impairing their protec-
tive role. The cuticle is a horny expansion of the
proximal nail fold that seals it to the nail plate,
protecting the underlying matrix, and its
removal can worsen nail fragility. Causes of
secondary nail fragility include systemic drugs,
such as retinoids and cancer chemotherapeutic
agents, systemic diseases, such as severe iron
deficiency, and traumatic and dermatological
nail diseases. These conditions may impair nail
matrix activity, leading to the growth of a weak,
fragile nail plate, or may mechanically damage
the existing nail plate.
Nail fragility can present an important cos-
metic problem, which may also interfere with
everyday activities [4]. Patients usually com-
plain that their nails are dry, weak, easily
breakable and unable to grow long [4, 5]. The
nail plate surface loses its shine and
smoothness.
Treatment of brittle nails is usually a big
challenge for dermatologists, due to the slow
growth rate of the nail plate and the difficulty in
getting actives to penetrate the nail tissue. One
of the main goals for successful topical therapy
is the cosmetic acceptability of the product,
which must be applied for several months to
obtain clear results. Thus, the ideal topical
product for nail fragility should be easy to
apply, with no sticky texture or unpleasant
odor, and should not leave an appearance of
‘‘varnished’’ nails: these characteristics will
improve adherence to treatment in male and
female patients and, in turn, improve the
efficacy.
The aim of our studies was to evaluate the
efficacy, tolerability and patient compliance of
a new topical nail-strengthening treatment
containing cationic hyaluronic acid and mastic
oil (Pistacia lentiscus).
METHODS
A preliminary 1-month study, subsequently
extended to 3 months, in Portugal, and a
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second 6-month study in Italy, included vol-
unteers with primary and secondary weak and
brittle nails. Globally, a cohort of 60 patients
was initially included in the study and evalu-
ated at 1 month. Seven subjects from the Por-
tuguese cohort were not invited to continue the
study after the first visit and 1 subject withdrew
before completing the 3-month study. There-
fore, 52 subjects were evaluated at 6 months.
For all patients, the diagnosis was established
on clinical grounds and from their medical
history. When suspected, onychomycosis was
excluded through clinical examination, direct
microscopy and/or culture. None of the patients
were receiving systemic or other topical
treatments.
Study Populations
Portuguese study: 30 female patients (mean age
46.28, from 23 to 63 years) with primary fin-
gernail fragility were evaluated for 1 month, of
which 23 continued to follow-up at 3 months of
treatment; however, one subject was lost to
follow-up at 3 months. Therefore, 22 subjects
were evaluated at 3 months.
Italian study: 30 patients, 9 males and 21
females (mean age 52.37, from 18 to 82 years).
In three patients nail fragility was due to tra-
chyonychia associated with alopecia areata, in
two patients it was due to onychotillomania
and in three patients it was due to mild nail
lichen planus confirmed by histopathology. In
one patient nail fragility was a result of chronic
paronychia. The other 21 patients were diag-
nosed as having idiopathic nail fragility,
involving the fingernails in 14 patients and the
toenails in seven patients.
Product Evaluated
The product tested is a new water-based nail-
strengthening solution specially formulated
with a combination of active ingredients (si-
lanediol salicylate and Pistacia lentiscus gum)
that increase the quantity and quality of silicon
and keratin in the nails. The gum from the tree
Pistacia lenticus contains numerous biologically
active molecules including essential oils of
which a-pinene, b-myrcene, b-pinene, linalool,
limonene and caryophyllen are the main con-
stituents. The polymer polymyrene represents
about 25% of the gum. The biologically active
substances are in part triterpenic acids
(C29–C31), including masticadienonic acid,
isomasticadienonic, oleanonic acid and mor-
onic acid. Pistacia lentiscus gum has demon-
strated in vitro that it increased the synthesis of
hard keratins (K31, K83, K85) and in vivo it
improved nail strength and thickness (data on
file). The product also contains cationic hya-
luronic acid that adheres to the surface and
deeply moisturizes the nails and cuticles. This
combination of ingredients (patent pending)
helps the natural process of nail repair and
growth. The product was applied to the entire
nail surface and the periungual tissues once
daily for 3 months (Portugal) or 6 months
(Italy).
Clinical Parameters
In both studies, the evaluation of treatment
efficacy and tolerability was performed after
2 weeks (V2), 1 month (V3), and 3 months (V4);
in the Italian study an additional 6-month
evaluation (V5) was performed (Figs. 1, Fig. 2).
Both studies evaluated the fragility of target
nails according to the investigator’s assessment
using a 4-point global assessment scale (GAS): 0
(clear of any sign of splitting, ridges or grooves;
normal nail plate thickness), 1 (mild tendency
to breakage; very few distal horizontal splits and
longitudinal grooves), 2 (moderate tendency to
breakage with horizontal splitting of the nail;
few deep ridges and longitudinal grooves; distal
longitudinal fissures of the nail plate free edge;
mild thinning of the nail) and 3 (severe lamellar
or transversal splitting; more than 70% of the
nail showing deep ridges and grooves; extended
longitudinal fissures of the nail plate margin; a
dramatic reduction of the nail plate thickness).
In addition, in both studies, patient assess-
ment scales (PAS) of treatment efficacy were
performed with a specific questionnaire with a
scale from 0 to 3, where 0 indicated no
improvement; 1, some improvement; 2, clear
improvement; and 3, very good improvement.
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For both studies, each follow-up visit (week
2, months 1, 3 and 6) included standardized
photos of the target nails, expert investigator
grading and subject-reported outcome
measures.
During and at the end of treatment, patients
were asked to give their opinion about the effi-
cacy and the cosmetic properties of the product
(e.g., ease of application).
Finally, the tolerability of the product was
evaluated through examination of
investigational areas (nails and skin around the
nails) and evaluation of other symptoms (pain,
stinging/burning) manifested by subjects at
each visit.
Evaluation Techniques
Confocal Microscopy
A Vivascope 1500 (Mavig GmbH, Munich,
Germany) in vivo confocal microscopy system
was used to obtain uniform imaging of the
Fig. 1 Portuguese study design. Assessments in 30 sub-
jects: global assessment scale (GAS), standardized pho-
tographs, physician global assessment (PGA), patient
assessment scale (PAS), questionnaire and tolerability. A
sub-analysis of 23 of the subjects was performed with
confocal microscopy, Primos 3D, and standardized pho-
tographs. With one drop-out, the study was extended for
22 subjects to 3 months
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nails. From these 2-dimensional images, the
total nail thickness, thickness of the superficial
layer of the nail, and the density of the nail were
assessed [6, 7].
PRIMOS 3D
PRIMOS (phaseshift rapid in vivo measurement
of skin) optical 3D is an in vivo optical mea-
surement device that uses a fringe projection
technique based on micromirror display devi-
ces. A fringe standard is projected on the nail
and detected by the system’s CCD camera. The
3D effect is calculated from the deflection in the
fringes which provides quantitative informa-
tion on the nail profile [8, 9].
The standard roughness was calculated from
the full aligned image. The parameters
evaluated were Ra (arithmetic mean of nail
surface) and Rz (mean of the 5 highest ‘‘peaks’’
and 5 lowest ‘‘valleys’’ in the image area).
Onychoscopy
Onychoscopy evaluation was supported and
documented by standardized dry videoder-
moscopy (Fotofinder Thricoscan) of the target
nail. The evaluation used a 4-point ony-
choscopy assessment scale (OAS), from 0 (clear
of any sign of splitting, ridging or grooves) to
?3 (severe lamellar o transversal splitting, more
than 70% of the nail showing deep ridging and
grooves; extended longitudinal fissures of the
nail plate margin).
Fig. 2 Italian study design. Assessment in 30 subjects:
global assessment scale (GAS), onychoscopy assessment
scale (OAS) and patient assessment scale (PAS) performed
at all follow-up visits. A sub-analysis of 10 of the subjects
was performed with reflectance confocal microscopy
(RCM) and optical coherence tomography (OCT)
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Dynamic Optical Coherence Tomography (D-
OCT)
D-OCT was performed on the top of the nail
plate through the proximal nail fold and from
the end of the nail plate through the distal
margin of the considered nail, by means of a
commercially available D-OCT (VivoSight:
Michelson Diagnostics Ltd, Maidstone, UK) and
3D image reconstruction software. The Vivo-
Sight OCT scanner uses eye-safe infrared laser
light to obtain a 3D block of image data at a
high resolution (\ 10 lm). OCT has a central
wavelength of 1305 nm and scans an area of
6 mm by 6 mm up to a depth of 2 mm. D-OCT
allows the description of blood flow in vivo and
visualization of the tissue microvasculature. In
order to minimize normal anatomical variation,
the same depth was chosen for all images using
the software tool ‘‘OCTFITTER’’ (University of
Modena and Reggio Emilia, Modena, Italy) that
provide horizontal D-OCT images at three
selected depths (150, 300 and 500 lm) [10–12].
Reflectance Confocal Microscopy (RCM)
RCM (VivaScope 3000: Mavig GmbH, Munich,
Germany) was used to visualize the nail plate. It
uses a diode laser at 830 nm and\22 mW
power at the tissue level, for the in vivo imaging
of nails with cellular resolution. Each individual
RCM image corresponds to a horizontal section
of approximately 1 9 1 mm, at a selected tissue
depth, with a lateral resolution of 1 lm. Cro-
damol oil was employed as a coupling medium
between the probe and the nail surface. The
images were taken from the top of the nail plate
through the nail bed and at the distal margin of
the nail. RCM and D-OCT (cross-sectional and
en face) images were obtained from each patient
before, during, and after the application of the
nail gel for qualitative visual comparison [13].
Reflectance confocal microscopy (RCM) (Vi-
vaScope 1500) assessed the total nail thickness,
the thickness of the superficial layer of the nail
and the density of the nail. The parameters were
measured according to a routine that included a
two-dimensional evaluation of the image of the
nail obtained. The results were presented in
pixels.
Ethical Consideration
Due to the cosmetic nature of the intended use
of the product studied, ethics committee
approval was not required. Both studies were
performed in line with the Declaration of Hel-
sinki (1964) and its subsequent amendments. In
both studies, the subjects were informed about
the expected benefits of the tested products and
the constraints of study participation and
signed an informed consent form, including
consent for the use of photographs taken during
the studies, prior to the start of the studies.
Statistical Analyses
Portuguese study: values are expressed as the
mean and standard deviation (SD). A Will-
coxon’s test for paired samples was performed
to evaluate changes between the data obtained
at baseline and at each time-point. Differences
were considered significant at p\ 0.05. Statis-
tical analysis was performed using SPSS software
(version 20.0; SPSS Inc, Chicago, IL, USA).
Pool analysis: the analysis has been carried
out on the set of data from the different indi-
vidual databases of each of the aggregate stud-
ies, taking into account that exactly the same
information has been collected with the same
schedule. Continuous variables have been
described by the number of valid cases, mean
and standard deviation. Comparisons of cate-
gorical variables have been made using the chi-
square test. In the case of continuous variables,
the Student t-test was used for independent
data. For all comparisons a level of statistical
significance of 0.05 bilateral was considered. All
analyses were performed on the data set using
all available information with intention to treat
(ITT) criteria. Statistical analysis was performed
using the SAS (Statistical Analysis System) pro-
gram, version 9.2.
RESULTS
In total, 60 subjects were included in the two
studies. In the Portuguese study, 30 subjects
enrolled for 1 month of treatment and 23
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females continued to the extension part of the
study to 3 months of treatment; however, one
subject was lost to follow-up at 3 months.
Therefore, 22 subjects were evaluated at
3 months.
In the Italian study, 30 patients were enrol-
led and completed the 6-month study.
Three-month data were available for 52
patients and 6-month data for 30 subjects.
No treatment-related side effects were
recorded.
Clinical Evaluation via Global Assessment
Scale (GAS) for Both Studies
In both studies the same evaluated parameters
have been considered at the same time points.
So the data have been presented individually
and pooled for these parameters.
In the Portuguese study the subjects pre-
sented a statistically significant improvement in
GAS scores at 14 days (GAS = 1.6 ± 0.5),
1 month (GAS = 1.2 ± 0.5) and 3 months
(GAS = 1.1 ± 0.4) versus the GAS score
obtained before treatment (1.8 ± 0.5)
(p\ 0.05). At 1 month of treatment, the per-
centage decrease in GAS and, therefore,
improvement in nail condition, was 31.8%
versus D0. Moreover, at 1 month and 3 months
of treatment, 3% and 4.5% of subjects, respec-
tively, obtained complete resolution with a
GAS = 0.
In the Italian study, at the end of the
6 months of treatment, 17 of 30 patients
(56.67%) obtained considerable improvement,
the majority associated with complete resolu-
tion of the nail plate abnormalities (GAS = 0)
(Fig. 3); improvement was noted both in fin-
gernails and toenails (Fig. 4). Six patients (20%)
showed a mild improvement (GAS = 1) while
the remaining seven patients (23.3%) remained
stable (GAS = 2). In total, 76% of the patients
showed an improvement in their nail appear-
ance. When considering patients with sec-
ondary nail fragility, the two patients with
onychotillomania had total resolution of nail
plate abnormalities, despite the presence of
periungual blood crusts demonstrating the
persistence of the habit tic. A completely heal-
thy nail was seen in the patient affected by
chronic paronychia at the 6-month visit, with
improvement of the nail plate and of the peri-
ungual tissues and regression of the proximal
nail fold inflammatory signs (Fig. 5). Marked
improvement of nail plate resistance with a
decrease in longitudinal fissures was also seen in
the three patients with mild nail lichen planus.
With all the study data pooled together, the
subjects presented statistically significant
improvement in GAS scores at 14 days (GAS =
1.7 ± 0.6), 1 month (GAS = 1.4 ± 0.7) and
3 months (GAS = 1±0.7) versus the GAS score
obtained before treatment (1.9 ± 0.5)
(p\ 0.0001). In total, 52% (n = 60) and 86%
(n = 52) of the patients showed a decrease in the
GAS assessment score and, therefore, an
improvement in their nail appearance at
1 month and 3 months, respectively.
Fig. 3 Complete resolution of idiopathic fingernail fragi-
lity and distal splitting after 6 months of treatment:
clinical examination shows a smooth shiny nail plate with
regular free edge (a, b); onychoscopy shows a regular nail
plate surface and hydrated healthy cuticle and periungual
skin (c, d)
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Patient Assessment Scale (PAS) and Self-
Questionnaire
In both studies, the patients evaluated the
improvement of the nail after application of the
product through patient global assessment. In
the Portuguese study, 90%, 100% and 100% of
the subjects reported some nail improvement at
14 days, 1 month and 3 months, respectively,
and in the Italian study, 93%, 100% and 100%
reported some nail improvement at these same
assessment points. Pooling the results from the
2 studies, 92%, 100% and 100% of patients
evaluated some kind of nail improvement at
14 days, 1 month and 3 months, respectively. In
addition, the 3-month results data pooling
showed that 20/52 (38.4%) patients reported a
very good or clear improvement and 12/52
(23%) reported some improvement; none
reported ‘‘no improvement’’.
In the Portuguese study, all patients also
defined the product as easy to apply, with a
pleasant texture and cosmetic qualities, as it did
not leave sticky residues on the nail and peri-
ungual tissues: overall, 95.2% of the subjects
had a positive general opinion of the product.
All patients reported that their nails were
smoother, more hydrated, with an improved
appearance including the cuticles (see Table 1).
In the Italian study, all patients reported that
the product was easy to apply and quickly
absorbed without leaving residues in the
applied areas. In fact, almost all of the patients
had excellent compliance and defined the
Fig. 4 Complete resolution of idiopathic toenail fragility
after 6 months of treatment: clinical examination shows
disappearance of longitudinal grooves and superficial scales
(a, b); onychoscopy shows a smooth nail plate surface with
regular distal margin and hydrated healthy cuticle and
periungual skin (c, d)
Fig. 5 Noticeable improvement of fingernail fragility in a
patient affected by chronic paronychia after 6 months of
treatment: clinical examination shows regrowth of a
healthy cuticle and a smooth shiny nail plate (a, b);
onychoscopy shows a regular nail plate surface and
decreased scaling and inflammation of the periungual
tissues (c, d)
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product as aesthetically pleasing and effective
with improvement evident from the beginning.
Instrumental Evaluations
Onychoscopy assessment at the end of the
6-month study revealed that signs of splitting,
ridges and grooves had completely disappeared
in 16 patients (53.33% OAS = 0) (Figs. 3, 4); 10
patients (33.33%) still showed very few distal
signs of nail fragility (OAS ?1) (Fig. 5) and only
4 patients (13.33%) still had a few deep ridges
and longitudinal grooves (OAS ?2). Observa-
tion of the periungual skin showed complete
disappearance of scaling with normally
hydrated skin and a healthy cuticle in all cases
(Fig. 4).
Confocal microscopy showed a statistically
significant increase in thickness of the superfi-
cial layer in the subjects’ most representative
nail at 1 month and 3 months, representing an
increase of 12.8% at 1 month versus initial data.
Nail density was also evaluated in the study,
showing a significant statistical increase in nail
density of 20.4% at 1 month and 39.8% at
3 months versus initial data.
PRIMOS 3D evaluation showed a statistically
significant decrease in Ra — that is, an anti-
roughness effect — after 1 and 3 months. The
mean roughness (Ra) decreased 5.8%, 8.1% and
Table 1 Portuguese study: users’ responses on the efficacy and cosmetic qualities of the product
Question % Subjects in agreement
The product hardens the nails 93.3
The product leaves nails hydrated 93.3
The product helps stop nails breaking 86.7
The nail surface is smoother 83.3
The overall appearance of the nails is improved 93.3
After application nails feel cared for 96.7
After application nails feel comfortable 96.7
Nails are more beautiful 90.0
The appearance of the cuticles is improved 73.3
Nails grow faster than before 76.7
Nails feel protected 86.7
The nails now have a more natural color 80.0
The product is easy to apply 100
The product spreads easily on the nail 100
The product has a pleasant fragrance 86.7
The product has a pleasant texture 100
The product does not leave a sticky sensation on the nails 93.3
The product does not leave sticky residues on the nails 93.3
The product packaging is easy to use 90.0
I have never seen packaging for a nail product like this 90.0
This packaging makes the application of the product more reliable 96.7
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17.1% versus baseline after 14 days, 1 month
and 3 months of product application, respec-
tively. The evaluation of the Rz parameter
showed a similar trend.
D-OCT evaluation before treatment (V1)
showed a nail plate characterized by an irregu-
lar, wavy aspect with a rough surface in all the
patients evaluated. Longitudinal ridges were
also observed and appeared as multiple
hyporeflective grayish to black full-thickness
grooves, parallel to each other, resembling the
‘‘string of beads’’ sign on dermoscopy. These
OCT signs were observed on the top of the
proximal and medial nail plate, while delami-
nation and breakage of the nail plate were visi-
ble on the free margin. All these OCT features
were milder in seven patients and more pro-
nounced in three patients. At the end of the
study, in all patients the nail appeared harder
and thicker and the aspect of the nail plate was
more regular and less wavy, with a reduction in
the hyporeflective grayish grooves. Longitudi-
nal ridges and distal splits were still observed
only in 3 severe cases, but they were fewer and
less deep. The improvement was evident at both
the proximal and distal part of the nail plate
(Fig. 6). Measurement of nail thickness before
treatment and after 3 months revealed a statis-
tically significant increase in the thickness of
the superficial layers of the nail plate (? 7.5%),
the part that undergoes distal splitting and
ridging when the nails are brittle. Nail density
also increased during the treatment period, with
a 20.4% increase and a 38.9% increase after 1
and 3 months, respectively. D-OCT evaluation
of nail roughness showed decreased nail
roughness evident after only 2 weeks of treat-
ment (- 5.5%) and a 19.2% decrease in nail
roughness at the 3-month follow-up visit.
RCM evaluation before treatment (V1)
revealed a homogeneous presence of canaliform
ridges on the top of the nail plate with bright
white pin-point structures with a homogeneous
distribution at the free margin of the nail. At the
end of the study (V5), RCM revealed a clear
reduction in the canaliform ridges and bright
white pin-point structures, especially in the less
severe patients. The nail plate appeared brighter
and more regular.
DISCUSSION
Treatment of brittle nails is often a challenge for
the dermatologist, for two main reasons: (1) it is
difficult for the actives to penetrate the nail
plate and particularly to penetrate simultane-
ously both the nail plate and periungual tissues.
The nail plate acts as a hydrophilic membrane,
so topical ointments, creams and greasy prod-
ucts cannot penetrate it and have no
Fig. 6 D-OCT of the distal nail of the patient from Fig. 1, (a) before and after 6 months of treatment: the nail plate surface
is more regular and hydrated (b)
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therapeutic effect [14]. The opposite is true of
the periungual skin, which should also be a
target of therapy, as the health of the nail plate
is a result of the normal function of the nail
matrix and the protective role of the proximal
and lateral nail folds. Most of the available
treatments only target the nail plate, as they are
generally some form of hydrophilic lacquer or
gel that deposit a coating on the nail plate. (2)
The nail has a very slow growth rate and topical
therapies need several months of use before
showing any efficacy. If a product does not have
good cosmetic qualities and is difficult to apply,
compliance with treatment stops quickly,
before seeing any results.
The water-soluble nail strengthener con-
taining Pistacia lentiscus and hyaluronic acid
tested in this study is specifically designed to be
both effective and easy to use. The gel comes
out from a ‘‘pen’’ with a simple click and it is
easy to dose: 1 click per nail. Application is
quick and easy: the brush is run over the peri-
ungual tissues and the nail plate, easily spread-
ing a transparent gel with a pleasant texture
that does not leave a sticky sensation or residue
on the nails. Compared with other products on
the market for the treatment of nail fragility,
the new gel is more convenient: it is easy to
carry and apply, and combines treatment for
the nail plate and for the cuticle and periungual
tissues. Of note, 90% of the patients who com-
pleted the study, including males, would buy
the product and 95% would recommend the
product to others.
The innovative combination of ingredients
(patent pending) of this gel formulation
explains its quick and marked efficacy:
1. Hyaluronic acid boosts hydration capacity,
a fundamental requirement since brittle
nails are a sign of dehydration and appear
when the amount of water in the nails is
reduced to less than 16% [15, 16]. The new
patent-pending formulation of hyaluronic
acid contained in the water-soluble nail
strengthener has a very high adhesive
capacity, due to its positive charges, which
makes it possible for the product to stay
longer on the skin and nails. This charac-
teristic is particularly important when
dealing with dryness of the nails. Moreover,
as the product is spread on the cuticle and
periungual skin, it acts as a moisturizing
agent in this sensitive area of the nail
apparatus. The periungual tissues are an
important component of the nail apparatus,
acting as protective barriers against pene-
tration of irritants and allergens into the
nail matrix (cuticle) and the lateral nail
plate margins (lateral folds): their integrity
is therefore a prerequisite for a healthy
resistant nail plate. The periungual skin
can be damaged in several exogenous and
endogenous nail conditions, e.g., chronic
paronychia, hand contact dermatitis, psori-
asis and mechanical nail dystrophies. An
effective treatment for nail fragility should
therefore target both the nail plate and the
periungual skin, providing hydration and
restoring its normal keratinization.
2. Mastic oil is an aromatic vegetable resin
produced by the plant Pistacia lentiscus. Its
active components stimulate the synthesis
of hard keratins and keratin-associated pro-
teins, increasing nail thickness and
strength. It has been demonstrated in vitro
that it increased the synthesis of hard
keratins (K31, K83, K85) and in vivo it
improves nail strength and thickness (data
on file).
3. Exogenous silicium supports nail growth
and improves the nail appearance. Silicium
is also a normal component of the skin and
its addition to the periungual tissues rein-
forces their normal growth.
Out of the clinical results, an in vitro study
has been performed with the water-soluble gel
nail strengthener, using a well-defined bovine
hoof membrane model [17] to evaluate the nail
treatment efficacy. After 14 days of application,
the tested product showed a statistical
improvement in firmness and surface charac-
teristics of the nails at the same level as a ref-
erence product Betralfatrus, while no
improvement was found with vehicle alone
(data on file).
Another innovation of this study lies in the
methods used to evaluate nail brittleness before
and after treatment. Besides investigator and
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patient evaluation, which are important in any
trial, and reflect the overall effectiveness and
tolerability of a product, we also used highly
sophisticated, objective techniques: full nail
photographs, onychoscopy, dynamic optical
coherence tomography (D-OCT), and reflec-
tance confocal microscopy (RCM).
Onychoscopy is one of the best tools for
evaluating nail fragility and tendency to break,
as it allows observation at high magnification of
the nail surface: a normal nail plate is shiny and
smooth, without longitudinal or transverse
creases and grooves; the distal margin is regular
and not split [18]. In contrast, brittle nails show
longitudinal and transverse ridges and grooves,
lamellar splitting and longitudinal fissures.
D-OCT and RCM have only recently been
applied to the study of nail dystrophies [19–21].
They are expensive and sophisticated tech-
niques that allow for the first time the mea-
surement of different nail parameters in vivo: in
our study, by using D-OCT and RCM we were
able to measure nail thickness, density and
roughness, providing a new and objective eval-
uation of nail fragility treatment.
In both studies the results were consistent
when using the same clinical scales for
evaluation.
One limitation of the studies is their open-
label design; however, the objective criteria
used, such as onychoscopy, PRIMOS 3D, con-
focal microscopy, OCT, and RCM support the
results obtained.
CONCLUSIONS
In conclusion, the results obtained in both
clinical studies indicate that this new product
containing hyaluronic acid and Pistacia lentiscus
is an effective, safe, and easy-to-use option for
topical treatment of nail brittleness and ten-
dency to breakage. Moreover, its ease of appli-
cation and cosmetic qualities facilitate better
treatment compliance. The modern and
sophisticated techniques used in these clinical
trials allow us to demonstrate a true efficacy of
this topical product in improving nail resistance
and thickness and hydrating and protecting the
periungual skin.
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